Prostate cancer is a global cancer burden and considerable effort has been made through
the years to identify biomarkers for the disease. Approximately a decade ago, the potential of …

Prostate cancer has a long disease history and a wide variety and uncertainty in individual
patients' clinical progress. In recent years, we have seen a revolutionary advance in both …

Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Background The use of 12-core systematic prostate biopsy is associated with diagnostic
inaccuracy that contributes to both overdiagnosis and underdiagnosis of prostate cancer …

Background Men suspected of having clinically significant prostate cancer (sPC)
increasingly undergo prostate MRI. The potential of deep learning to provide diagnostic …

Background The benefit of antibiotic prophylaxis is uncertain when performing transperineal
prostate biopsies. Judicious use of antibiotics is required as antimicrobial resistance …

Purpose Improved logistics and availability led to a rapid increase in the use of [18 F]-PSMA-
1007 for prostate cancer PET imaging. Initial data suggests increased uptake in benign …

Background Intraductal carcinoma (IDC) and cribriform architecture (CA) represent
unfavorable subpathologies in localized prostate cancer. We recently showed that IDC …

Executive summary Prostate cancer is the most common cancer in men in 112 countries,
and accounts for 15% of cancers. In this Commission, we report projections of prostate …

Purpose: Prospective validation of 68Ga prostate specific membrane antigen positron
emission tomography/computerized tomography is lacking in initial staging of prostate …